KSWA
CORT icon

Kathleen S. Wright Associates’s Corcept Therapeutics CORT Stock Holding History

Kathleen S. Wright Associates’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$65.3K Hold
786
– – 0.02% 139
2025
Q2 		$57.7K Hold
786
– – 0.02% 141
2025
Q1 		$89.8K Hold
786
– – 0.04% 130
2024
Q4 		$39.6K Hold
786
– – 0.02% 159
2024
Q3 		$36.4K Buy
+786
New +$27.9K 0.02% 168

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Kathleen S. Wright Associates's CORT Position: Q3 2025 in Review

Kathleen S. Wright Associates held its Corcept Therapeutics (CORT) position steady in Q3 2025 at 786 shares worth $65.3K. The position accounts for 0.02% of the portfolio, ranked #139.

Kathleen S. Wright Associates first reported a position in CORT in Q3 2024 and has held it in 5 quarters since. The position peaked at $89.8K in Q1 2025. 429 funds tracked by Wall St. Rank hold CORT as of Q3 2025.

  • Kathleen S. Wright Associates held 786 shares of Corcept Therapeutics worth $65.3K as of Q3 2025.
  • Kathleen S. Wright Associates left its Corcept Therapeutics share count unchanged in Q3 2025.
  • Corcept Therapeutics made up 0.02% of Kathleen S. Wright Associates's portfolio in Q3 2025, its #139 holding.
  • Kathleen S. Wright Associates first reported a position in Corcept Therapeutics in Q3 2024 and has held it in 5 quarters since.
  • Kathleen S. Wright Associates's Corcept Therapeutics position peaked at $89.8K in Q1 2025.
  • 429 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2025.

Based on Kathleen S. Wright Associates's 13F filing for Q3 2025, filed 10 Oct 2025.